Research!America and Global Health Experts Focus on the Economic and Health Burden of Neglected Tropical Diseases in the U.S.
Leading researchers discuss emerging health threats at panel discussion
During a panel discussion today at Tulane University’s School of Public Health and Tropical Medicine, hosted by Research!America, several researchers and leading public health experts said the nation must increase public awareness and research to address the emergence of neglected tropical diseases (NTDs) in the U.S.
NTDs, commonly associated with the developing world, have recently been identified in many parts of the country including Louisiana. Factors such as increased globalization, trade, migration, urban sprawl or climate change have been cited as potential underlying causes for the emergence of NTDs in the U.S. Chagas disease, which can cause heart failure, affects more than 300,000 people across the nation and costs the U.S. an estimated $1 billion in health care and lost productivity each year. Researchers at Loyola University New Orleans identified the first locally acquired case of Chagas disease in Louisiana. Continue reading →
New Report Highlights Economic Burden of Chagas
On February 7, The Lancet Infectious Diseases published an enlightening report on the global economic impact of Chagas disease. Chagas, a parasitic disease transmitted through insects called “kissing bugs,” infects nearly 10 million people worldwide, including 300,000 here in the U.S. Some people can carry the disease without knowing they have it, while others can experience debilitating respiratory infections and potentially lethal heart complications. The study examines in detail both the global and domestic economic cost of Chagas disease, which rival better publicized infections such as Lyme disease, and illustrates the urgent need for research for new tools to fight this disease.
-Ian Bradley, Research!America intern
Recognizing Public Health Heroes
On September 30, The Washington Post highlighted efforts in Haiti to eliminate lymphatic filariasis, commonly known as elephantiasis. A neglected tropical disease (NTD), elephantiasis is a parasitic infection spread by mosquitoes that can lead to swelling of the arms or legs — sometimes severely enough that individuals with the disease are stigmatized or unable to work. The good news is that elephantiasis can be prevented with anti-parasitic medicines. The Centers for Disease Control and Prevention and the U.S. Agency for International Development’s NTD program have taken a leadership role in administering these drugs in countries that are affected by elephantiasis. U.S. public health professionals have joined forces with local public health professionals and helped to organize programs, provide technical assistance and monitor progress. Through the collaborative efforts of these invaluable individuals, nine countries have already been declared free of elephantiasis. With support from the CDC and international charities, the Haitian health ministry is working hard to distribute this life-saving medication and join the list of countries free of elephantiasis.
This kind of outstanding work by public health professionals happens every day all around the world. Although there is no risk of elephantiasis in America, there are other NTDs emerging in the U.S. such as Chagas disease, West Nile virus and dengue fever. The CDC and other public health professionals play a crucial role in treating these diseases and organizing prevention and education campaigns here at home. These tireless individuals keep our drinking water safe, our air clean and our children healthy. Please join Research!America and other public health organizations in recognizing these public health heroes on November 19 for Public Health Thank You Day. For more information or to learn how you can get involved, please visit www.researchamerica.org/ph_thank_you or like our PHTD Facebook page at www.facebook.com/PHTD1.
-Morgan McCloskey, global health intern